Signal intensity curve at different porosities. by Qingsong Zhang (3353270)

“…Initially, the decay follows a logarithmic pattern, whereas, at later stages, the attenuation exhibits a gradual and smooth decrease. …”

<i>Schistosoma haematobium</i> prevalence in hotspot implementation units (IUs) in annual school-based surveys (A) and household-based surveys (B) of the SchistoBreak study in Pemb... by Lydia Trippler (10136316)

Effects of clonal integration and <i>Bacillus subtilis</i> on total flavonoids (A, C, E) and chlorogenic acid (B, D, F) of the basal, apical portion, and whole fragment of <i>Glech... by Bing-Nan Zhao (21553401)

Differential abundance scores of differential metabolic pathways (classified according to Pathway_Hierarchy) (A) mild PTOA group VS severe PTOA group (B) mild PTOA group VS normal... by Peng-fei Han (694841)

Projected global leukemia burden, 1990-2050. by Chengjun Hu (588206)

“…<div><p>Background: Leukemia is a prevalent form of cancer that encompasses four primary subtypes, posing significant health risks. …”

Correlation between HDI and EAPC. by Chengjun Hu (588206)

“…<div><p>Background: Leukemia is a prevalent form of cancer that encompasses four primary subtypes, posing significant health risks. …”

Global leukemia incidence and EAPC, 1990-2021. by Chengjun Hu (588206)

“…<div><p>Background: Leukemia is a prevalent form of cancer that encompasses four primary subtypes, posing significant health risks. …”

Structure–Activity Relationships of Azaquinazolinone Derivatives as ¹⁸F‑Labeled PET Probes Targeting Ghrelin Receptors by Hiroyuki Watanabe (312793)

“…Among them, AQ-12 showed the highest binding affinity for GHSR. In a biodistribution study using normal mice, [¹⁸F]AQ-12 displayed high uptake in the pancreas, which is one of the GHSR-expressing organs, and its radioactivity was significantly decreased by coinjection with unlabeled AQ-12. …”

Temperature effects on populations of <i>S. haematobium</i> and <i>S. mansoni</i> infections. by Zadoki Tabo (12415261)

DDC for four anticoagulants from 2019 to 2023. by Wei Luo (80175)

“…</p><p>Results</p><p>From 2019 to 2023, the DDDs of rivaroxaban demonstrated a significant annual increase in most hospitals (<i>p</i> < 0.05). …”

Isotype control overlays. by Chen Lu (135200)

“…<div><p>Decompression sickness is a fatal disease worldwide. Therefore, to find a prophylactic modality for decompression sickness is urgently required. …”

Original uncropped blot. by Chen Lu (135200)

“…<div><p>Decompression sickness is a fatal disease worldwide. Therefore, to find a prophylactic modality for decompression sickness is urgently required. …”

Raw Data. by Chen Lu (135200)

“…<div><p>Decompression sickness is a fatal disease worldwide. Therefore, to find a prophylactic modality for decompression sickness is urgently required. …”

Identification of BM-MSCs. by Chen Lu (135200)

Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Outpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

The expenditure on anticoagulants in the period of 2019-2023(million CNY). by Wei Luo (80175)

Phosphate solubilizing microorganisms with clear halozone produced by, (A) Sw-T1, (B) Pu-T2, and (C) Pu-T4 isolates. by Riri Dayang Sari Risman (21696244)

Effects of BM-MSCs on different types of lung cell death in different group. by Chen Lu (135200)